Treatment of peripheral vascular disease with misoprostol (Cytotec): a pilot study. Misoprostol, the oral analogue of alprostadil, was used to treat 20 patients (aged 40-60 years) with peripheral arterial disease (PAD) according to Fontaine's classification at stages IIa and IIb. All patients received 200 micrograms of misoprostol 3 times a day during a month. The therapy with misoprostol resulted in clinical improvement in all patients. Elongation of pain-free (before treatment: 129 m +/- 78 m after treatment: 214 m +/- 109 m) and maximum walking distance (before treatment: 304 m +/- 169 m